Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.00% | $2.00M | €450.59B | 80.13% | 76 Outperform | |
| HSBC Holdings | 2.15% | $1.43M | £202.74B | 35.68% | 80 Outperform | |
| Roche Holding AG | 1.79% | $1.19M | CHF256.31B | 21.75% | 73 Outperform | |
| British American Tobacco | 1.67% | $1.11M | £97.95B | 42.78% | 71 Outperform | |
| Shell (UK) | 1.58% | $1.05M | £189.65B | 27.87% | 73 Outperform | |
| Sumitomo Electric Industries | 1.54% | $1.03M | ¥8.10T | 255.96% | 74 Outperform | |
| Commonwealth Bank of Australia | 1.44% | $960.11K | AU$290.49B | 22.06% | 64 Neutral | |
| Siemens | 1.43% | $953.38K | €167.96B | -4.39% | 74 Outperform | |
| Novartis AG | 1.37% | $914.99K | CHF230.97B | 25.96% | 80 Outperform | |
| AstraZeneca | 1.34% | $894.77K | $295.60B | 19.89% | 80 Outperform |